The 1st International Electronic Conference on Clinical Medicine
15–30 Sep 2021
Cardiology, Oncology, Pulmonology, Neurology and Stroke Neurology, Gastroenterology Hepatopancreatobiliary Medicine, Endocrinology Metabolism, Stomatology, Nephrology Urology, COVID19
- Go to the Sessions
- 1. Cardiology
- 2. Gastroenterology and Hepatopancreatobiliary Medicine
- 3. Oncology
- 4. Infectious Diseases
- 5. Pulmonology
- 6. Clinical Neurology
- 7. Endocrinology & Metabolism
- 8. Nephrology & Urology
- 9. Stomatology
- 10. Orthopedics
- 12. Obstetrics and Gynecology
- 13. Clinical Psychology
- 14. Otolaryngology
- 15. Epidemiology & Public Health
- 16. Nuclear Medicine & Radiology
- 11. Clinical Hemostaseology
- 17. Poster
- Event Details
- Welcome from the Chair
- Event Real Time Data
- Conference Chairs
- List of Accepted Submissions
- Live Session - Hemostaseologic Challenges for the Clinician
- Live Session - New aspects in Gestational Diabetes Mellitus (GDM)
- Live Sessions Recordings
- Conference Speakers
- Videos from Invited Speakers
- Instructions for Authors
- Event Awards
- Conference Secretariat
- Sponsors and Partners
- Editions in this series
Winners Announcement ------ Best Poster Award & Best Paper Award
Welcome from the Chair
On behalf of the organizing committee, you are cordially invited to participate in the first International Electronic Conference on Clinical Medicine. This event aims to bring together researchers working in the field of clinical medicine, to present and discuss their recent contributions, without the need for travel. Participation is free of charge for authors and attendees. In addition, there will be webinars organized during this e-conference.
This conference will address and promote all the multi-disciplinary aspects of clinical medicine. The topics of interest include, but are not limited to:
- Gastroenterology and Hepatopancreatobiliary Medicine
- Infectious Diseases
- Neurology and Stroke Neurology
- Clinical Psychology
- Obstetrics and Gynecology
- Endocrinology & Metabolism
- Nephrology and Urology
- Epidemiology & Public Health
- Nuclear Medicine & Radiology
All submitted abstracts will be reviewed by the conference committee. The authors of accepted contributions will be invited to submit a conference paper, along with a slide or video presentation, or a poster presentation of their work. All participants will have the opportunity to examine, explore, and critically engage with research findings published in Sciforum during the conference.
After the conference, all accepted papers will be published in the proceedings of this e-conference within a dedicated issue of the MDPI journal Biology and Life Sciences Forum. In addition, all participants will be encouraged to submit a full paper to be considered for publication in the Journal of Clinical Medicine (JCM), with a 10% discount on the APC. JCM is an open access journal from the MDPI, in the field of clinical medicine. The journal is indexed in the Sciences Citation Indexing Expended (SCIE IF=3.303), and other databases. Full texts are archived in PubMed Central (PMC).
We are very enthusiastic about this first Electronic Conference in JCM and are relying on you to make it successful.
Chair and committee of first International Electronic Conference on Clinical Medicine
Department of Internal Medicine, University Hospital of Strasbourg, Strasbourg, France
Dr. Emmanuel Andrès is Editor-in-Chief of JCM since 2018. He is very active and knows the journal very well. He has good reputation with h-index of 28. His research interests are drug-induced cytopenias; anemia; thrombocytopenia; neutropenia; cobalamin deficiency; vitamin B12 deficiency; telemedicine; chronic diseases; chronic heart failure.
Department of Neuroscience, Reproductive and Odontostomatological Sciences University of Naples "Federico II", Naples, Italy
Prof. Dr. Gianrico Spagnuolo received a D.D.S. degree and he completed his Ph.D. in Dental Materials Biotechnology at University of Naples “Federico II”, Italy. He had been Visiting Assistant Professor and Adjunct Scientist at the Department of Operative Dentistry and Periodontology at University of Regensburg (Germany). He was associate researcher at Interdisciplinary Research Centre on Biomaterials (CRIB) - University of Naples “Federico II” and he completed the three-year postgraduate program in Oral Surgery at the same University. He has served as Professor of Operative Dentistry at Sechenov University, Russia. Now he is Associate Professor at School of Dentistry - University of Naples “Federico II” spending his time teaching, giving lectures and participating in the faculty practice in Endodontic, Operative Dentistry and Oral Surgery sections. Prof. Dr. Spagnuolo research is focused on the interaction between cell-tissue-materials at molecular and clinical levels. Prof. Gianrico Spagnuolo has published over 100 articles in impacted scientific journals and he is Academic Editor of several indexed journals.
Department of Acute Care Medicine, University of Tokyo, Tokyo, Japan
Dr. Doi received his M.D. and Ph.D., and residency training at the University of Tokyo Hospital, followed by research in nephrology training at NIH/NIDDK (2005–2007). At the University of Tokyo, Dr. Doi is a clinical and basic research investigator. His research interests include acute kidney injury, sepsis, and multiple organ failure. His current research involves the AKI biomarker, sepsis-induced AKI, and organ system network analysis in multiple organ failure. Dr. Doi is a council member of the Japanese Society of Intensive Care Medicine, Councilor and Board Certified Nephrologist of the Japanese Society of Nephrology, and a Board Certified Senior Member of the Japanese Society for Dialysis Therapy. Dr. Doi has published over 190 scientific articles and has delivered over 15 presentations at scientific meetings. He is an Associate Editor for the Journal of Intensive Care and Editorial board member for Kidney International and other journals.
Department of Psychology, Educational and Science and Human Movement, University of Palermo, Palermo, Italy,
Department of Sciences for Health Promotion and Mother and Child Care "G. D'Alessandro", University of Palermo, Palermo, Italy
Prof. Dr. Roccella graduated in Medicine and Surgery and Specialization in Child Neuropsychiatry at the University of Palermo, Italy. He obtained the title of Research Dottere in the neuropsychopathology of learning processes in developmental age, at the II University of Naples, Faculty of Medicine, Naples, Italy. He received the Board of Qualìfìcatìon in Headache Disorders, La Sapienza University of Rome, Faculty of Medicine, Rome, Italy. He holds the "Diplôme Interuniversitaire de MYOLOGIE des Universités AIX-Marseille II et Paris VI-Pierre et Marie Curie, Faculté de Médicine", Paris, France. He deals in particular with neurodevelopmental and autistic spectrum disorders, neuropsychological disorders in children with epilepsy and rare genetic syndromes, and psychopathological disorders in developmental age. He is the author of over 450 scientific publications that are published in national and international journals, some of which have also been the subject of reports and communications in national and international conferences. He is the author of 12 monographs and many chapters in national and international editions. He is part of the editorial board of many international journals.
Department of Dermatology, Kyushu University, Fukuoka, Japan
Prof. Furue graduated from the School of Medicine, University of Tokyo as M.D. in 1980. He was an associate professor, at Yamanashi Medical University from 1992–1995, and moved to the University of Tokyo as an associate professor in 1995. He has been a chairman and professor of the Department of Dermatology, Kyushu University since 1997. He is the editor-in-chief of Journal of Dermatology and Journal of Clinical Medicine (Dermatology Section). His research interests are in the areas of atopic dermatitis, cutaneous neoplasms, dioxins/aryl hydrocarbon receptor and antioxidants.
atopic dermatitis, cutaneous neoplasms, dioxins/aryl hydrocarbon receptor and antioxidants
Department of Obstetrics and Gynecology, Soroka University Medical Center, Beer-Sheva, Israel,
Faculty of Health Sciences, Ben-Gurion University of the Negev, Negev, Israel
Prof. Dr. Sheiner served as the director of the Residency Program and as the deputy director general of the hospital. His PhD study and ultrasound fellowship at Rush University Medical Center (Chicago, Il) were supported by a grant from the Fulbright Visiting Scholar Program of the United States. Professor Sheiner has published extensively in the area of perinatal epidemiology, and has more than 540 peered-reviewed publications. He is the editor of 10 books and a member of the editorial board of six scientific journals.
Department of Clinical and Experimental Medicine, second Psychiatric Unit, Santa Chiara University Hospital, University of Pisa, Pisa, Italy
Dr. Prof. Maremmani received his MD degree in Medicine from the University of Pisa, Italy, in 1979, and his specialization in Psychiatry in 1983. He has been a qualified full professor of Psychiatry since 2014. At present, he is part of the board of the directors of the Department of Specialty Medicine, at Santa Chiara University Hospital, University of Pisa, Italy. He received the Dole–Nyswander Award, Washington, DC, USA, April 22, 1994; the EUROPAD “Chimera” Award ad honorem, Paris, France, November 3, 2004; the Member of Honor of SEPD (Spanish Society of Dual Pathology, Barcelona, March 20, 2015; the Fellow of International Society of Addiction Medicine (FISAM), Montreal, October 20, 2016—ISAM Ambassador for Italy. His research program is focused on dual disorder patients, notably opioid use disorder patients, with a focus on their clinical aspects and treatment. Prof. Maremmani has published over 290 scientific articles and has delivered over 300 presentations at scientific meetings. He is the Editor in Chief for Heroin Addiction and Related Clinical Problems (1999–today); Italian Journal of Addictions (2018–today) and Journal of Clinical Medicine—Section of Psychiatry (2019–today).
clinical aspects and treatment of dual disorder patients; opioid use disorder; heroin use disorder; pain and addiction
Department of Pediatric Pharmacology and Pharmacometrics, University Children’s Hospital Basel, University of Basel, Basel, Switzerland,
Division of Clinical Pharmacology, Children’s National Hospital, Washington, DC, USA
Dr. van den Anker received his M.D and Ph.D. degree from the Erasmus University in Rotterdam, the Netherlands, and is currenly the Eckenstein–Geigy Distinguished Professor in Pediatric Pharmacology in Basel, Switzerland, and the Evan and Cindy Jones Endowed Chair of Pediatric Clinical Pharmacology in Washington, DC. His research program is focused on developmental, neonatal and pediatric pharmacology. Dr. van den Anker has published over 450 scientific articles and has delivered over 200 presentations at scientific meetings. He has been funded by the Swiss National Foundation and the National Institutes of Health for decades.
Department of Surgical–Medical Sciences and Translational Medicine, University of Rome “Sapienza”, Rome, Italy
Prof. Signore is presently the Head of the Nuclear Medicine Unit, Department of Medical–Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, “Sapienza” University of Rome, Italy, and he is an honorary full professor at the Department of Nuclear Medicine and Molecular Imaging, University Medical Center, Groningen, the Netherlands. He is also the dean of the Technical Faculty for Radiology and Nuclear Medicine (TSRM) in Sora (FR) and vice-director of the Specialization School of Nuclear Medicine of “Sapienza” University of Rome. He graduated in Medicine in 1984, then specialized in Endocrinology (1987) and Nuclear Medicine (1991). He obtained a PhD in 2007 at the University of Groningen, the Netherlands. He has been a visiting professor in Nuclear Medicine, University of Ghent, Belgium; Consultant of the International Atomic Energy Agency (IAEA) of United Nations Organization (UNO); past-president of the International Society of Radiolabelled Blood Elements (ISORBE); secretary and past-president of the International Research Group in Immunoscintigraphy and Therapy (IRIST); past-president of the international scientific association Nuclear Medicine Discovery (Nu.Me.D.). From a scientific point of view, he is the promoter of 14 PhD students; the author of over 250 scientific publications in national and international journals (total citations = 9200, H index = 52); the editor of seven books; as well as the author of more than 35 book chapters and he has deposited five international patents. Amongst the many awards and recognitions, a notable one worth mentioning is his recent award for best Basic-Science publication in the Journal of Nuclear Medicine in 2015; the “Marie Curie” award of the European Association of Nuclear Medicine (EANM), in 2004; the “Masahiro Iio” award of the World Federation of Nuclear Medicine and Biology (WFNMB), in 1994.
nuclear medicine; infection imaging; inflammation imaging; thyroid cancer imaging; pre-clinical imaging; imaging immuno-therapy; imaging autoimmune diseases
Otolaryngology, Head and Neck Surgery Unit, Flinders Medical Centre, Adelaide, Australia,
College of Medicine and Public Health, Flinders University, Adelaide 5001, Australia
Eng Ooi is an associate professor at Flinders University and holds the positions of head of Otolaryngology Head and Neck Surgery at Flinders Medical Centre, SA chair of training, and RACS board member of Otolaryngology. Eng is a surgeon scientist who completed surgical training in South Australia with FRACS and a PhD for his thesis on innate immunity pathogenesis in chronic rhinosinusitis. He undertook an advanced Rhinology, Skull Base, Head and Neck fellowship in Toronto with Professor Ian Witterick in 2009–2010. His clinical practice covers Rhinology, Skull Base, Head and Neck Oncology and OSA surgery. He leads the Flinders ENT research group collaborating with multiple specialties and scientists. His current translational research interests focus on breath and blood biomarkers for cancer detection and surveillance, clinical trials, quality of life and patient-reported outcome measures with surgery, oropharyngeal dysphagia, and BiZact tonsillectomy. He currently has 69 journal publications, three book chapters and received 16 research grants and scholarships. He is an editorial board member for five journals and an invited reviewer for eight surgical journals. He supervises PhD and Masters students and directs the Rhinology fellowship program at Flinders.
School of Health and Wellbeing, University of Southern Queensland, Ipswich, QLD 4305, Australia
Professor Lindsay Brown is a pharmacologist researching functional foods as potential treatments for chronic diseases such as metabolic syndrome including hypertension, obesity and fatty liver, inflammatory bowel disease and chronic kidney damage. His research has a h-index of 54 with over 230 peer-reviewed publications and over 10,000 citations.
Department of Thoracic Surgery, European Institute of Oncology, Via Giuseppe Ripamonti 435, 20141 Milan, Italy
Dr. Gasparri research is focused on lung cancer early diagnosis by biological fluidsanalysis. This research line has as its ultimate goal the development of alternative means that are non-invasive or painful and economic, in order to be applied to the entire population at risk. The results obtained from these studies have been published or will be published in recognized scientific journals (see the bibliography or ORCID ID n. 0000-0001-7922-7061).To achieve this important goal Dr. Gasparri has won several grant (see Grant History) that have founded his projects. The importance of dissemination of results and scientific activity is underlined by the participation of Dr. Gasparri in various national and international conferences.Moreover, he is a reviewer for different scientific journals, such as Journal of Breath Research (ISSN 1752-7163), Therapeutics and Clinical Risk Management (ISSN 1178-203X), Sensors (ISSN 1424-8220), Chemosensor (ISSN 2227-9040).
Department of Medical and Surgical Sciences, Magna Graecia University, 88100 Catanzaro, Italy
Prof. Salvatore De Rosa served at the Federico II University in Naples, the University of Bonn (Germany), Vienna (Austria), Santiago de Compostela (Spain), and at the Goethe University of Frankfurt (Germany) and currently works as an Interventional Cardiology and Associate Professor of Cardiology at the “Magna Graecia” University of Catanzaro (Italy). His research interests are focused on the pathophysiology of atherosclerosis, thrombosis and vascular biology, including the role played by non-coding RNAs. Prof. De Rosa was the recipient of multiple research grants and was recognized Fellow by the ESC (Scientific Excellence), the SIC (Scholar in Cardiology), and GISE.
Respiratory Translational Research Group, Department of Laboratory Medicine, College of Health and Medicine, University of Tasmania, Launceston, TAS 7248, Australia
Dr Sukhwinder Singh Sohal is Head of the Respiratory Translational Research Group and Senior Lecturer in Laboratory Medicine at University of Tasmania, Australia. He is Board Director, The Thoracic Society of Australia and New Zealand (TSANZ). Dr Sohal also serve on the Medical and Scientific Advisory Panel of lymphangioleiomyomatosis (LAM) Australia Research Alliance and the European Board for Accreditation in Pneumology. In 2016, Dr Sohal was recognised with the prestigious Australian Commonwealth Government Innovative Science & Technology Award for his work on EMT in COPD. Dr Sohal is a clinical translational researcher focusing on chronic lung disease. His lab is also home to investigations looking at effects of electronic smoking devices on lung health. Dr Sohal has published over 100 peer reviewed articles.
Department of Medical Sciences, University of Turin, c.so AM Dogliotti 14, 10126, Turin, Italy
Prof. Marilena Durazzo is presently the Head of Internal Medicine 3 Unit, Molinette Hospital of Turin, and a Confirm Associate Professor of Internal Medicine, University of Turin. She is also Vice-Director of Hospital Department of General and Specialistic Medicine and Director of the Specialization School of Geriatrics. She graduated in Medicine in 1978, then specialized in Gastroenterology (1982). During 90’s she has been a visiting scientist in Internal Medicine, University of Hannover, Germany. Prof. Durazzo is author of more than 140 publications in scientific international journals with Impact Factor, about 20 book chapters and a monography. Nowadays, her main fields of scientific and research interest include Chronic Viral Hepatitis, Non-Alcoholic Steatohepatitis, Metabolic Syndrome and Gastroenterological problems in the elderly.
Departments of Public Health Sciences and Physical Therapy, College of Health Professions, Wichita State University, Wichita, Kansas, USA
Dr. Hand received his PhD degree in Physiology from Southwestern Medical Center at Dallas, USA. He is currently the Dean of the College of Health Professions and a Professor of Public Health Sciences and Physical Therapy at Wichita State University at Wichita, USA. His research program spans the physiology and psychobiology of exercise and stress, HIV/AIDS, physical activity and energy utilization, and practical application of activity interventions in chronic conditions. Dr. Hand’s research team has published over 150 refereed scientific articles and book chapters and over 275 scientific abstracts. His work has been presented on five continents, and he has been funded by United States’ federal and state agencies, foundations and corporations and industry.
Department of Translational Medicine, Section of Neurology, University of Piemonte Orientale, 28100 Novara, Italy
Cristoforo Comi received his M.D. degree from the University of Milan, Italy, board certification in neurology, and Ph.D. degree in molecular medicine from the University of Piemonte Orientale and a Neurology Fellowship from Mount Sinai Hospital, NYC, USA. He is Associate Professor of neurology and head of the neuroimmunology lab at the University of Piemonte Orientale, Novara, Italy. Since 2019, he is also head of the Neurology division at S. Andrea Hospital in Vercelli. His area of expertise includes the molecular bases of neurodegenerative and neuroinflammatory diseases. His main research achievements are regarding T-cell apoptosis in neuroinflammatory diseases and the study of proinflammatory genes and cytokines in neurodegenerative diseases. Current studies are concerned with the role of immunity in neurodegeneration, with a special focus on identifying biomarkers of disease progression. Prof. Comi serves as editor and reviewer for several international indexed scientific journals, as well as for national and international public and private funding agencies.
Department of Radiology, Stanford University, Stanford, CA, USA
Arutselvan Natarajan, PhD (bio and pharmaceutical chemistry) is Senior scientist at the Molecular imaging program at Stanford. He has been focusing on clinical translation research over two decades for cancer diagnosis and imaging using probes. These probes are ranging from small molecules to antibodies of various protein formats for cancer patients (e.g., breast, NHL and liver). Several of these tracers were successfully translated into clinical studies, or under process for human patient imaging. In addition, he is equally developing novel engineered protein molecules for several cancer targets, including immune checkpoints for the small animal PET/CT, US and optical imaging strategy with humanized mouse models, these pre-clinical studies were performed prior to clinical studies.
Ospedale Policlinico San Martino, University of Genova, Genoa, Italy
Prof. Simone Ferrero has taken the degree in Medicine in 1999 and the specialization in Obstetrics and Gynaecology in 2004. He currently serves as Associate Professor of Obstetrics and Gynaecology at the University of Genova (Italy). In 2006, the obtained the European University Diploma of Gynaecological Operative Endoscopy at the l'Université Auvergne, Clermont-Ferrand, France and in and in 2007 he obtained the Diplôme D’Université de Chirurgie Laparoscopique at the Université Strasbourg, Strasbourg, France. In 2009, he obtained the PhD at the Queen Mary University of London. As regards the scientific activity, he has published more than 300 articles in peer-reviewed journals, the Hirsch Index (H-index) is 43. He has given more than 100 presentations in national and international meetings. The main areas of his clinical research include endometriosis, uterine myomas, gynaecological surgery and gynaecological oncology. The main areas of this basic research include endometriosis and ovarian cancer.
2. Gastroenterology and Hepatopancreatobiliary Medicine
4. Infectious Diseases
6. Clinical Neurology
7. Endocrinology & Metabolism
8. Nephrology & Urology
12. Obstetrics and Gynecology
13. Clinical Psychology
15. Epidemiology & Public Health
16. Nuclear Medicine & Radiology
11. Clinical Hemostaseology
List of accepted submissions (24)
|Id||Title||Authors||Presentation Video||Poster PDF|
Antimicrobial Potential Of Hydroxymethylglutaryl-Coa Reductases Inhibitors
Submitted: 18 Feb 2021
Abstract: Show Abstract
Bacterial resistance to antibiotics represents a serious and worrying public health problem worldwide. Considering this scenario, the reuse of drugs already known is presented as a quick and less expensive opportunity, being considered an attractive alternative for the development of new drugs and treatments, this study proposes the contemplation of an ecumenical scenario on the antimicrobial potential of statins, in this context, its objective is to carry out a narrative review of the scientific literature, providing a basis for future research and new possibilities in the face of this public health problem. Narrative review was used as a method to conceive the state of the art and support a pertinent appreciation of the theme. To initiate the investigation, a guiding question was prepared to conduct the entire research process, using the PICo strategy (Population / Interest / Context). The scientific literature presents studies that reveal the antimicrobial potential of statins against different bacterial strains. The antibacterial activity appears to be a specific statin / specific bacterium, with an emphasis on simvastatin and atorvastatin, and Gram-positive bacteria, particularly S. aureus, as well as rifampicin adjuvant activity in the fight against mycobacteria.
RISKS ASSOCIATED WITH THE USE OF PSYCHOTROPICS IN PATIENTS DIAGNOSED WITH COVID-19
, , ,
Submitted: 26 Mar 2021
Abstract: Show Abstract
|, , ,||N/A||N/A||
In the context of the pandemic, negative implications for mental health have increased considerably, as well as the existing associations of psychotropics in this period to combat the new coronavirus. In view of this, the present integrative review aimed to verify the health impact of covid-19 infection in patients with mental disorders who use psychotropics. As a result, the co-administration of these drugs represented a great risk at the systemic level, and can be lethal in certain cases. Thus, careful evaluations must be taken in order to implement an effective intervention that meets the needs of patients, always considering the risks of these drug associations.
INFLUENCE OF INTESTINAL INFLAMMATORY DISEASES ON GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH COVID-19
Submitted: 26 Mar 2021
Abstract: Show Abstract
COVID-19 is characterized by pulmonary involvement, which has generated a large number of hospitalizations and studies worldwide, motivating researchers in search of a possible treatment and development of vaccines for the disease. However, other symptoms related to SARS-CoV-2 were less relevant in relation to studies published to date. Thus, there is a need to establish a relationship between patients with inflammatory bowel diseases and the symptoms of the gastrointestinal tract caused by COVID-19, since the involvement of the gastrointestinal tract affects up to 53% of patients who contract SARS-CoV-2 . In this perspective, the present study is an integrative review carried out at the Virtual Health Library and PubMed based on the health descriptors: gastrointestinal diseases and COVID-19, applying the Boolean operator “AND” between them. The selection criteria used were the eligibility criteria: articles in Portuguese, English and Spanish, published between December 2019 and July 2020. Individuals with inflammatory bowel diseases, even with greater expression of ACE2, are not at increased risk of symptoms or worsening. Thus, based on the relationship between pre-existing symptoms and the symptoms of the new COVID-19, health professionals, based on their clinical experience, will be able to compose prophylactic measures and manage patients with COVID-19 and gastrointestinal symptoms more effectively.
Effect of potassium intake on the regulation of the ENaC renal epithelial channel in primary arterial hypertension: A systematic review
Submitted: 28 Mar 2021
Abstract: Show Abstract
The balance between sodium and potassium represents a key point for the regulation of hypertension and in recent years, scientific research has contributed to its understanding from molecular to epidemiological aspects. This review aims to show evidence of regulation of the ENaC channel by the intake of potassium for the control of primary hypertension. The epithelial sodium channel -ENaC- regulated by the renin-angiotensin-aldosterone system at the renal level, is essential for sodium homeostasis and the maintenance of arterial hypertension, and several medical investigations have generated drugs that inhibit activation pathways for sodium action on blood pressure; also, observational, interventional and experimental studies in humans and animals demonstrate the consequences of increased sodium intake. In this context, potassium intake is suggested as a more comprehensive treatment for the control of arterial hypertension, acting at the molecular level with decreased activation of the ENaC channel by normalizing sodium and potassium concentrations, reducing sensitivity to the development of cardiovascular diseases; Moreover, nutritional evidence shows that populations with natural foods rich in fruits and vegetables that exceed potassium intake (150 mEq per day) and minimize sodium intake (20-40 mEq per day) suffer arterial hypertension at a rate of less than 3%, without negative effects on lipid balance, catecholamines, and ion concentrations in the kidney.
Development of a stacking-based ensemble machine learning for detection of depression in Parkinson's disease
Submitted: 09 Apr 2021
Abstract: Show Abstract
The primary symptom of PD is dyskinesia, but as Parkinson's disease (PD) progresses, non-motor symptoms such as depression are more likely to occur. According to previous studies, even though patients with PD frequently experience depression, only 1% of them recognized depression by themselves. These results suggested that it would be needed to diagnose Parkinson's disease depression as soon as possible. Previous studies that evaluated the factors related to Parkinson's disease depression in South Korea reported that neuropsychological level, health factors, socioeconomic status, education level, age, spouse, and social activities affected Parkinson's disease depression. Since regression analysis was mainly used as a modeling method to predict depression, they were efficient in identifying individual risk factors. However, they were limited in identifying compound-risk factors such as sociodemographic variables and living habits. Moreover, since regression analysis assumes independence, normality, and homoscedasticity, there is a possibility of producing biased results when the model is developed using data in violation of normality. As a way to overcome the limitation of the regression model, Classification is a machine learning technique has been widely used in Clinical decision supporting system and medical artificial intelligence. Machine learning can analyze data accurately even if the data somewhat violate the assumption of normality such as nonlinear data in the estimation process. In particular, Classifier Ensemble has a better accuracy than a single classifier, so active research has recently been conducted. The objectives of this study were to develop a model for predicting Parkinson’s disease depression based on stacking-based ensemble machine learning. This study was conducted with resources of'Parkinson's Disease Epidemiology Data' from National Biobank of Korea, the Centers for Disease Control and Prevention, Republic of Korea. This study analyzed 280 subjects who were 60 years or older with Parkinson's disease. Depression was measured using 30 items of Geriatric Depression Scale (GDS). This study was combined with base learners by stacking, in which a meta-learner (meta-classifier) was served to combine the predictions of base learners. A random forest was determined to play the role of meta-learner. This study compared the prediction performance of each model and determined that a model with the highest accuracy with 0.6 or higher sensitivity and specificity as the best model. If models have the same accuracy, the model with the high sensitivity value was selected as the best prediction model. This study suggests that stacking-based ensemble machine learning may be more effective in predicting Parkinson's disease depression than a single classifier.
Live Session - Hemostaseologic Challenges for the Clinician
Chaired by Prof. Dr. Bernhard Lämmle .
Date and Time: 16 September 2021, 17:00 (CEST - Central Europe)
Prof. Dr. Bernhard Lämmle
Emeritus Professor and Director, Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
Senior Professor, Center for Thrombosis and Hemostasis, University Medical Center Mainz, Johannes Gutenberg University, Mainz, Germany
Visiting Professor, Haemostasis Research Unit, University College London, London, UK
Assoc.-Prof. Cihan Ay
Associate professor in medicine/haemostaseology at the Medical University of Vienna, Austria, and was a visiting research professor at the University of North Carolina at Chapel Hill, NC, USA (2016-2017).
Prof. Dr. Katrien Devreese
Professor in Hematology/Coagulation at the Ghent University (Belgium) and head of the department of Laboratory Medicine at the Ghent University Hospital.
Prof. Dr. Marie Scully
Consultant haematologist at UCLH and Professor of haemostasis and thrombosis at UCL.
- 17:00 - Cihan Ay: Cancer-associated thrombosis: Risk, prevention and treatment.
- 17:30 - Katrien Devreese : Laboratory diagnosis of antiphospholipid syndrome : What clinicians should know.
- 18:00 - Bernhard Lämmle : Diagnosis and management of thrombotic thrombocytopenic purpura.
- 18:30 - Marie Scully: COVID-19-vaccine-induced immune thrombocytopenia and thrombosis (VITT).
For many clinicians «hemostaseology» remains a somewhat mysterious and rather exotic science reserved for specialists. In this Session we present 4 different clinically relevant topics which should be of great interest in daily practice. Cancer-associated thrombosis, Antiphospholipid syndrome, Thrombotic thrombocytopenic purpura and Vaccine-induced thrombocytopenia and thrombosis will be presented by experts focussing on the state-of-the-art clinical approach.
Attendance to this Live Session is FREE. However, registration will be necessary, as the number of participants is limited.
Live Session - New aspects in Gestational Diabetes Mellitus (GDM)
Chaired by Prof. Eyal Sheiner.
Date and Time: 17 September 2021, 18:00 (IDT - Israel) / 17:00 (CEST - Central Europe) / 11:00 (EDT - Toronto)
Prof. Eyal Sheiner, MD, PhD
Deichmann-Lerner Professor and Chairman, Department of Obstetrics and Gynecology B, Soroka University Medical Center, Vice Dean, Student Affairs, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
Prof. Yariv Yogev, MD
Professor of Obstetrics and Gynecology. Chairman, Department of Obstetrics, Gynecology and Fertility, Chairman, Lis Hospital for Women, Tel Aviv Sourasky Medical Center Sackler Faculty of Medicine, Tel Aviv University.
Prof. Nir Melamed, MD
Professor of Obstetrics and Gynecology. Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
- Yariv Yogev, MD: Gestational diabetes mellitus: management with oral hypoglycemic agents.
- Nir Melamed MD: GDM in Twins: More Good than Harm?
- Eyal Sheiner MD, PhD: GDM, not only a gestational disease. Long-term complications to the mother and child.
Gestational diabetes mellitus (GDM) is one of the most common morbidities complicating pregnancy, which is steadily rising in prevalence, with short- and long-term consequences to the mothers and child. Management and treatment aim to achieve the best possible glycemic control, while avoiding hypoglycemia and ensuring maternal and fetal safety. They involve behavioral modifications, nutrition and medications, and specifically insulin, if needed. Oral hypoglycemic agents, such as glyburide (second-generation sulfonylurea) and metformin (biguanide), are attractive alternatives to insulin due to lower cost, ease of administration, and better patient adherence.
With a distinguished panel of Professors, Yariv Yogev, Nir Melamed and Eyal Sheiner, this webinar will address and share new perspectives on the prevention and monitoring of GDM.
Attendance to this Live Session is FREE. However, registration will be necessary, as the number of participants is limited.
Live Sessions Recordings
Live Session 1: Hemostaseologic Challenges for the Clinician
Live Session 2: New Aspects in Gestational Diabetes Mellitus (GDM)
Department of Obstetrics and Gynecology, Soroka University Medical Center, Beer-Sheva, Israel
Eyal Sheiner, MD, PhD is Deichmann-Lerner Full Professor. He is the Chairman of Department of Obstetrics and Gynecology B at the Soroka University Medical Center, and the Vice Dean, Student Affair, Faculty of Health Sciences, Ben-Gurion University of the Negev. His PhD study and ultrasound fellowship at Rush University Medical Center (Chicago, Il) were supported by a grant from the Fulbright Scholar Program of the United States. Professor Sheiner has published extensively in the area of perinatal epidemiology, and has more than 560 peered-reviewed publications. He is the editor of 10 books.
Department of Obstetrics, Gynecology and Fertility, Lis Hospital for Women, Tel Aviv Sourasky Medical Center, Israel,
Sackler Faculty of Medicine, Tel Aviv University, Israel
Prof. Yariv completed his clinical and research fellowship in Maternal Fetal Medicine at Columbia University and St. Lukes-Roosvelt Hospital in New York. Currently, He is a Professor of Obstetrics and Gynecology in Tel Aviv University and the Chairman of Lis Hospital for Women, in Tel Aviv Sourasky Center (Ichilov) which is a tertiary University affiliated Hospital. Prof. Yogev is the past President of the Israel Society for Maternal and Fetal Medicine, past moderator of the diabetes in pregnancy program in the American Society for Maternal Fetal Medicine (SMFM)
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
Dr. Melamed is a staff physician in the Maternal-Fetal Medicine Division at Sunnybrook Health Sciences Centre, Toronto, Canada, and an Associate Professor at University of Toronto. Dr. Melamed is the recipient of the Waugh Family Chair in Twin Research at the University of Toronto and is the Director of the Sunnybrook Twin Research Center (https://twincentre.sunnybrook.ca/). Dr. Melamed has co-authored over 180 original research papers. His main topics of interest include twin pregnancies, placental disease, and fetal growth.
Fetal Maternal Unit B, Division of Obstetrics and Gynecology, Soroka University Medical Center, Ben Gurion University of the Negev, Israel
Gali Pariente, MD, Senior Lecturer at the Ben Gurion University of the Negev, acting director of Fetal- Maternal Unit B in the Division of Obstetrics and Gynecology at the Soroka University Medical Center. Trained in the Faculty of Heath Science at Ben Gurion University, and after a fellowship program at the University of Toronto, Dr. Pariente is a Maternal and Fetal Medicine specialist, provides care for women with pregnancy complications. Hence, Dr. Pariente devotes her research to clinical as well as epidemiological and basic science aspects of human pathological conditions during pregnancy. Dr. Pariente has published studies regarding pregnancy complications and long-term maternal and offspring morbidity of different ethnical populations of the Negev District.
Department of General Gynecology and Gynecologic Oncology, Medical University of Vienna, Vienna, Austria
• Born 1973 Austria • Graduated from Medical School in Vienna, 1998 • Residency in Gynecology and Obstetrics, University Hospital Vienna • Promotion to Associate Professor of Gynecology and Obstetrics, 2004 2009-2011 Head of department of Gynecology and Obstetrics, Al Ain Hospital, Abu Dahbi, U.A.E. 2012-2013 Head of department of Gynecology, Barmherzige Brüder, Vienna, Austria 2017 Consultant of Gynecology and Obstetrics, Medical University Vienna 2017-2019 Clinical and Research Fellowship program in Urogynecology and Reconstructive Pelvic Floor Surgery after international criteria of EUGA; (Department of General Gynecology and Gynecologic Oncology; MUV) 2019-ongoing Head of urogynecologic working group and urogynecologic OPD (urogynecology and reconstructive pelvic floor surgery) within the Department of General Gynecology and Gynecologic Oncology, MUV International experience 2005, 2006 Volunteer at the Department of Obstetrics and Gynecology, St. Dominics Hospital, Akwatia, Ghana, Westafrica 2007 Volunteer at the Department of Gynecology, Dr. Iwamura Memorial Hospital&Research Center, Bhaktapur, Nepal: Implementation of an uterus prolaps center 2009 – 2011 Head of Department of Obstetrics and Gynecology, Al Ain Hospital, Al Ain, Abu Dahbi, U.A.E., collaboration project with the MUVI Publications Over 65 “peer reviewed” publications (follow publication list) Prize Scientific prize, at the 4th german urogynecologic congress, April 2012, Mainz, Germany Committee Board Member of the Research & Development Committee of the International Urogynecologic Association (IUGA) (12/2018-12/2020) Membership Austrian Society of Gynecology and Obstetrics (ÖGGG) Austrian Society of Urogynecology and Reconstructive pelvic floor surgery (AUB) (Board member) International Urogynecological Association (IUGA) und International Continence Society (ICS) EUGA (European Urogynecolgical Association)
Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy,
Colorectal Surgery, Vall d'Hebron University Hospital, Barcelona, Spain
Gianluca Pellino has an M.D. degree. He is Ph.D. in Traslational Medicine. and serves as Lecturer in General Surgery at the Università della Campania "Luigi Vanvitelli", Naples, Italy . He has served as Colorectal Surgeon at the Unit of Colorectal Surgery of University Hospital "La Fe", Valencia, Spain, as 2017 European Coloproctology Fellow. Dr Pellino has studied medicine at the Medical University of Naples and graduated in 2008. He completed the Residency Programme in General Surgery in 2016. He completed the ESCP 6-month Fellowship 2016 at the Colorectal Surgery Unit of the Royal Marsden Hospital, London. He attended the St. Mark's Hospital, Harrow, London in 2017 with an Erasmus+ Traineeship placement. Since 2019, he is Fellow of the Royal College of Surgeons on England (FRCS). He is a Fellow of the European Board of Surgery (FEBS) in coloproctology upon passing the exam of the European Board of Surgical Qualification (EBSQ-c) in 2018. In 2018 he received the status of International Fellow of the American Society of Colorectal Surgeons (FASCRS), and in 2020 the status of Fellow of the American College of Surgeons (FACS). He is former Regional Representative (Campania) of the Italian Society of Colorectal Surgery (SICCR) and former Website Committee Member of the European Society of Coloproctology (ESCP). He serves as member of the Guidelines Committee and Communication Committee of the ESCP, member of SICCR Research Committee. He has been co-chair of EuroSurg (2017-19), National co-Lead (Italy) for GlobalSurg 3 Study, and is local PI of several multicentric studies. He is vice-chair of ItSurg Collaborative. Dr Pellino is also Chairman of Young ESCP and a Member of the Young Committee (Y-ECCO) of the European Crohn's and Colitis Organisation (ECCO), he is Overseas Member of the Association of Coloproctology of Great Britain and Ireland (ACPGBI), Member of the Asociación Española de Coloproctología (AECP), Member of the Asociación Española de Cirujanos (AEC), Member of the Grupo Español de Trabajo en Enfermedad de Crohn y Colitis ulcerosa (GETECCU), Member
Department of Neurosurgery, Foundation IRCCS Istituto Neurologico “C. Besta”, via Celoria 11, Milano, Italy
Francesco Acerbi, MD PhD, is the Vice-Chair of the Neurovascular Unit and the head of the microsurgical laboratory at the Foundation IRCCS Neurological Institute “C.Besta” in Milano. Dr. Acerbi’s expertise includes cerebrovascular disorders (aneurysm, AVM, cavernomas, and moyamoya disease and stroke), brain, skull base and intramedullary tumors. He is a member of the Italian Society of Neurosurgery, European Association of Neurosurgical Society and Congress of Neurological Surgeons. Dr. Acerbi received his medical degree at the University of Pisa and a medical science diploma at the School of Advanced Study Sant’Anna of Pisa. He completed his neurosurgery residency at the University of Milano and his PhD in Neuroscience at the University of Milano. He completed a neurosurgical fellowship at the Department of Neurosurgery of the Free University of Brussels (Erasme Hospital), and a visiting fellowship at the Mount Sinai Hospital in New York. He took the Italian Qualification to Associate Professor in Neurosurgery in 2014 and to Full Professor in 2018. Dr. Acerbi’s research activities include the development of new surgical techniques for cerebral revascularization, anatomical studies of neurosurgical approaches, and the development of new visualization techniques during surgical approaches for oncological and vascular disease, in particular involving intraoperative fluorescence. He has received research fundings from MIUR and AIRC. He is author or coauthor of over 100 peer-reviewed articles and 6 book chapters (H-index 25 on Scopus).
Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland,
Center for Thrombosis and Hemostasis, University Medical Center Mainz, Johannes Gutenberg University, Mainz, Germany,
Haemostasis Research Unit, University College London, London, UK
Bernhard Lämmle, M.D., was Full Professor of Hematology and Director of the Department of Hematology and the Central Hematology Laboratory at the University Hospital of Bern, Switzerland, from 1989 until his retirement in July 2013. He then became a guest professor and senior consultant at the Center for Thrombosis and Hemostasis at the University Medical Center, Mainz, Germany. Since 2019 he is visiting professor at University College London Haemostasis Research Unit. His scientific interest concerns clinical and laboratory aspects of hematology, hemostasis and thrombosis with a special focus on thrombotic thrombocytopenic purpura and the metalloprotease ADAMTS13. Bernhard Lämmle has coauthored more than 300 publications and held many educational and state-of-the-art lectures at international congresses. He is recipient of an Investigator Recognition Award by the International Society of Thrombosis and Haemostasis (ISTH) (2003), a Distinguished Career Award by ISTH (2017) and holds Distinguished Emeritus membership of the American Society of Hematology.
Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria
Dr. Ay studied medicine at the Medical Univeristy of Vienna, Austria and Ruprecht-Karls-University, Heidelberg, Germany. He earned his degree (MD) from the Medical University of Vienna, Austria in 2006 and received there his medical training and completed specialisation in Internal Medicine, Haematology and Medical Oncology. Dr. Ay is currently an associate professor in medicine/haemostaseology at the Medical University of Vienna, Austria, and was a visiting research professor at the University of North Carolina at Chapel Hill, NC, USA (2016-2017). His research and clinical work focuses on venous thromboembolism (VTE), anticoagulation and bleeding disorders. Having contributed to over 200 peer-reviewed publications, he was particular successful in contributing to a better understanding of the etiology of VTE in cancer by identifying biomarkers and clinical risk factors for cancer-associated VTE. He has been an active peer reviewer for major medical journals in the field including the New England Journal of Medicine, British Medical Journal, Circulation, JACC, Blood, ATVB, Haematologica, Journal of Thrombosis and Haemostasis (JTH), Thrombosis Research and Thrombosis & Haemostasis (T&H), etc. He served as Co-Chair of the Scientific and Standardization Committee (SSC) Subcommittee of the International Society on Thrombosis and Haemostasis (ISTH) on Haemostasis and Malignancy until 2019, and as is an associate editor of Research and Practice in Thrombosis and Haemostasis (RPTH), the open access journal of ISTH. He further serves as board member oft he Austrian, German and Swiss Society on Thrombosis and Haemostasis Research (GTH) since 2019. Dr. Ay is a passionate clinician and researcher, supervisor of diploma and PhD-students and maintains regular teaching activities for students and health care professionals to foster education in the field of thrombosis and haemostasis.
Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium
Professor Katrien Devreese is professor in Hematology/Coagulation at the Ghent University (Belgium) and head of the department of Laboratory Medicine at the Ghent University Hospital. Professor Devreese obtained her Medical Degree at the Ghent University in Belgium followed by Specialization in Clinical Pathology/Hematology, and an Academic degree of Doctor in Medical Sciences (Ph.D.) with the thesis “The laboratory diagnosis of the antiphospholipid syndrome” at the Ghent University. She is chair of the Scientific Standardisation Subcommittee (SSC) on Lupus Anticoagulant/ Antiphospholipid Antibodies of the International Society of Thrombosis and Haemostasis (ISTH) (since 2017), following a period as co-chair (2012-2016). She is executive board member and treasurer of the International Society for Laboratory Hematology (ISLH). She was board member, secretary and treasurer of the Belgian Society on Thrombosis and Haemostasis from 2008-2019. Her research interests are focused on studies in the diagnostic field of Antiphospholipid Syndrome. She is an author of more than 180 A1 publications in the field of hematology/haemostasis, more than >220 posters/abstract presentations, and is frequently invited as speaker on many national and international congresses.
Division of Cardiology, Department of medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA
Andreas Kalogeropoulos, MD MPH PhD, is a clinical and outcomes researcher in cardiovascular medicine with expertise in heart failure, echocardiography, and research methodology. He graduated from the University of Patras, Greece (MD, 1994), where he completed his training in internal and cardio¬vascular medicine (2004) and research methodology (PhD, 2012). Dr. Kalogeropoulos trained in echocardiography, heart failure, and outcomes research (MPH, 2013) at Emory University. He has authored over 180 peer-reviewed articles and 3 book chapters. Dr. Kalogeropoulos has received research support from the National Institutes of Health, the American Heart Association, the American Society of Echocardiography, and the Atlanta Clinical and Translational Science Institute for his work on heart failure and echocardiography. He is the current Chair of the Research Committee of the Heart Failure Society of America (2019-2020) and has served on the research committees of the American Society of Echocardiography and the National Cardio¬vascular Data Registry. Dr. Kalogeropoulos has been serving on the Editorial Boards of the Journal of Cardiac Failure and the Journal of American Society of Echocardio¬graphy among other journals. His research focuses on (1) risk factors, outcomes, and clinical prediction models for patients with advanced heart failure, with the goal to optimize management of heart failure patients; (2) risk factors for incident heart failure at the population level, with the goal of primary and secondary prevention of heart failure; and (3) applications of echocardiography for patients with advanced heart failure and congenital heart disease.
Departments of Haematology, University College London, London, UK
Professor Marie Scully is a consultant haematologist at UCLH and Professor of haemostasis and thrombosis at UCL. My particular interests include platelet mediated disorders, specifically, ITP, TTP and aHUS and acquired bleeding and thrombotic conditions. Primary publications include TTP, in particular treatment and clinical subtypes, in conjunction with an understanding of the pathogenesis of the underlying disease. I am clinical lead for the national TTP service, UK TTP forum and patron for the TTP Network. I supervise postgraduate doctorates and am involved in undergraduate and postgraduate teaching and regularly reviews for haematology and related medical journals.
Videos from Invited Speakers
1. Caught in the Middle: Heart Failure with Midrange and Recovered Ejection Fraction
Dr. Andreas P Kalogeropoulos
Prof. Dr. Barbara Bodner-Adler
3. The contribution of Fluorescein in Modern Neurosurgery
Dr. Francesco Acerbi
4. Sars Cov-2 Vaccination in Pregnancy
Dr. Gali Pariente
5. Massive online Global Research Collaboratives: Experiences from the EuroSurg Collaborative
Instructions for Authors
- Scholars interested in participating in the conference can submit their abstract (about 200–300 words) online on this website until 31 May 2021;
- The Conference Committee will notify the acceptance of the abstract by 14 June 2021;
- In case of acceptance, authors will be asked to submit their manuscript, along with a slide presentation (in PDF) and optionally a video presentation of their paper, before the submission deadline of 12 July 2021;
- The manuscripts and presentations will be available on https://eccm.sciforum.net/ for discussion and rating during the time of the conference from 15 to 30 September 2021.
- All accepted proceeding papers will be published as one dedicated volume in MDPI Biology and Life Sciences Forum ( ISSN: 2673-9976 , https://www.mdpi.com/journal/blsf). Authors are also invited to elaborate their contributions into full manuscripts that will be considered for publication in the Journal of Clinical Medicine (JCM), with a 10% discount on the article processing charges (APC).
Proceedings papers must be prepared in MS Word using the Proceedings template indicated below, and should be converted to PDF format before submission.
Download the template files here:
The manuscript should count at least 3 pages (incl. figures, tables and references). There is no page limit on the length, although authors are asked to keep their papers as concise as possible. Carefully read the rules outlined in the 'Instructions for Authors' on the journal website, and ensure that your manuscript submission adheres to these guidelines.
Manuscripts should have the following structure:
- Full author names
- Affiliations (including full postal address) and authors' e-mail addresses
- Results and Discussion
For further inquiries, please contact us at email@example.com
Authors are encouraged to prepare a presentation in PowerPoint or similar software, to be displayed online along with the manuscript. Slides can be prepared the same way as for any traditional conference. They should be converted to PDF format before submission.
Authors are also encouraged to submit video presentations. This is an unique way of presenting your paper and discussing it with peers from all over the world. Video should be no longer than 10 minutes and prepared with one of the following formats: .mp4 / .webm / .ogg (max size: 250Mb). Videos should be submitted with the full manuscript by 12 July 2021.
Authors that wish to present a poster only, i.e., without the proceedings paper, can do so in Session 17. Posters of this conference. Posters will be available on this conference’s website during and after the event. Like the papers presented in the conference, participants will be able to ask questions and make comments about the posters. Posters that are submitted without a paper will not be included in the proceedings of the conference.
All authors must disclose all relationships or interests that could inappropriately influence or bias their work. This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. If there is no conflict, please state "The authors declare no conflict of interest." Financial support for the study must be fully disclosed under "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe that authors should retain the copyright to their scholarly works. Hence, by submitting a Communication paper to this conference, you retain the copyright of your paper, but you grant MDPI the non-exclusive right to publish this paper online on the Sciforum.net platform. This means you can easily submit your paper to any scientific journal at a later stage and transfer the copyright to its publisher (if required by that publisher).
To acknowledge the support of the conference’s esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to launch the Best Paper Awards and Best Poster Awards.
Number of Awards Available: 1The Best Paper Award is given for the paper judged to make the most significant contribution to the conference.
Number of Awards Available: 1The Best Poster Award has been established to recognize the scientific merit exhibited in poster presentation and preparation (for two candidates, with videos uploaded).
Terms and Conditions:
Best Paper Award
As a sponsor, JCM would like to award the best paper as elected by all the conference committee. The award will consist of 500 Swiss francs. We look forward to posting your contributions.
Criteria for Evaluation of Best Paper Award:
- Full paper must be submitted to ECCM 2021;
- Originality/novelty of the paper;
- Significance of content;
- Scientific soundness;
- Interest to the readers;
- English language and style.
- Each Evaluation Committee member will give an assessment for each applicant in terms of the criteria outlined above;
- Total score for each presentation will be ranked, from highest to lowest;
- If two or more authors get the same score, further evaluation will be carried out;
- All decisions made by the Evaluation Committee are final.
Best Poster Award
As a sponsor, JCM would like to grants an award (500 Swiss francs) for the best poster presented at the conference. This prize is awarded by a jury to the best designed poster presented at the conference.
Posters should have the following information.
- Title (with authors and affiliations);
- Contact information;
- Three minute video presentation.
During the conference, the chair is invited to judge the quality of the three minute video presentation and poster. Criteria of judgement on the presentation shall be the ability of summarizing the content of the work and motivating interest in looking at the poster. Criteria of judgement on the poster should be the clarity of poster and appearance quality.
Ms. Lily Pei
Ms. Vedia Zhang
Ms. Iris Wu
Ms. Janet Lv
4. Infectious Diseases
Dr. Silvia Nozza, San Raffaele Scientific Institute, Via Stamira d’Ancona 20, 20127 Milano, Italy
7. Endocrinology & Metabolism
Prof. Dr. Gianrico Spagnuolo, Department of Neuroscience, Reproductive and Odontostomatological Sciences University of Naples "Federico II", Naples, Italy
12. Obstetrics and Gynecology
Prof. Dr. Eyal Sheiner, Department of Obstetrics and Gynecology, Soroka University Medical Center, Beer-Sheva, Israel, Faculty of Health Sciences, Ben-Gurion University of the Negev, Negev, Israel
13. Clinical Psychology
Prof. Dr. Michele Roccella, Department of Psychology, Educational and Science and Human Movement, University of Palermo, Palermo, Italy,, Department of Sciences for Health Promotion and Mother and Child Care "G. D'Alessandro", University of Palermo, Palermo, Italy
Prof. Dr. Eng Ooi, Otolaryngology, Head and Neck Surgery Unit, Flinders Medical Centre, Adelaide, Australia, College of Medicine and Public Health, Flinders University, Adelaide 5001, Australia
15. Epidemiology & Public Health
Prof. Dr. Gregory A. Hand, Department of Epidemiology, Robert C. Byrd Health Sciences Center School of Public Health, West Virginia University, Morgantown, WV, USA
11. Clinical Hemostaseology
Prof. Dr. Bernhard Lammle, Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland, Center for Thrombosis and Hemostasis, University Medical Center Mainz, Johannes Gutenberg University, Mainz, Germany, Haemostasis Research Unit, University College London, London, UK